Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.

  • Okura T
  • Gong L
  • Kamitani T
  • et al.
304Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.

Abstract

Fas/APO-1 and TNF receptor 1 share a common signaling motif in their cytoplasmic tail called the "death domain." Using the death domain as bait in the yeast two-hybrid system, several death domain-containing proteins that participate in cell death signaling have been identified. Here we report the isolation of a novel protein, sentrin, which interacts with Fas/APO-1 and TNF receptor 1 but not with FADD/MORT1 or CD40. Two-hybrid interaction assays reveal that sentrin associates only with the signal-competent forms of Fas/APO-1 or TNF receptor 1 death domains. Sentrin is a novel protein of 101 amino acids with homology to ubiquitin, Nedd8, and a Saccharomyces cerevisiae protein, Smt3. When overexpressed, sentrin provides protection against both anti-Fas/APO-1 and TNF-induced cell death.

Cite

CITATION STYLE

APA

Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., … Yeh, E. T. (1996). Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. The Journal of Immunology, 157(10), 4277–4281. https://doi.org/10.4049/jimmunol.157.10.4277

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free